PDCD1 and neoplasm: To investigate the interplay between gut microbiota and anti-PD-1 therapy, We implanted MC38 cells subcutaneously to establish tumor models and examined the synergistic effect of gut microbiota and immunotherapy using broad-spectrum antibiotics (ATBs) (see “Materials and methods”) and a PD-1 inhibitor.